Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here